ALIZE PHARMA SAS has a total of 21 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CORTECS OM PTY LTD, APIM THERAPEUTICS AS and AEGERION PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Mexico | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ghigo Ezio | 18 |
#2 | Van Der Lely Aart Jan | 14 |
#3 | Brizzi Maria Felice | 6 |
#4 | Granata Riccarda | 6 |
#5 | Muccioli Giampiero | 4 |
#6 | Abribat Thierry | 3 |
#7 | Lely Aart Jan Van Der | 1 |
Publication | Filing date | Title |
---|---|---|
US2016151458A1 | Use Of Unacylated Ghrelin, Fragments And Analogs Thereof As Antioxidant | |
WO2013088241A1 | Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin | |
CA2723270A1 | Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease | |
WO2008145749A1 | Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders | |
CA2594214A1 | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
US2008159991A1 | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof |